Free Trial
OTCMKTS:GNMSF

Genmab A/S (GNMSF) Stock Price, News & Analysis

Genmab A/S logo
$320.00 +5.00 (+1.59%)
As of 09:58 AM Eastern

About Genmab A/S Stock (OTCMKTS:GNMSF)

Advanced

Key Stats

Today's Range
$320.00
$320.00
50-Day Range
$216.31
$335.77
52-Week Range
$170.00
$336.45
Volume
21 shs
Average Volume
2,783 shs
Market Capitalization
$21.14 billion
P/E Ratio
16.06
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Genmab A/S Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
7th Percentile Overall Score

GNMSF MarketRank™: 

Genmab A/S scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Genmab A/S.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Genmab A/S is 16.06, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 221.05.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Genmab A/S is 16.06, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 63.58.

  • Price to Book Value per Share Ratio

    Genmab A/S has a P/B Ratio of 3.97. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Genmab A/S's valuation and earnings.
  • Percentage of Shares Shorted

    0.14% of the outstanding shares of Genmab A/S have been sold short.
  • Short Interest Ratio / Days to Cover

    Genmab A/S has a short interest ratio ("days to cover") of 99.7, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Genmab A/S has recently increased by 58.20%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Genmab A/S does not currently pay a dividend.

  • Dividend Growth

    Genmab A/S does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.14% of the outstanding shares of Genmab A/S have been sold short.
  • Short Interest Ratio / Days to Cover

    Genmab A/S has a short interest ratio ("days to cover") of 99.7, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Genmab A/S has recently increased by 58.20%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Genmab A/S has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.76 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Genmab A/S this week, compared to 2 articles on an average week.
Receive GNMSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GNMSF Stock News Headlines

Is Genmab’s Rally Justified After Strong Quarterly Results in 2025?
Get the #1 trade setup delivered to you every market day
While most traders are distracted by headlines and crash calls, the New Money Crew — Graham Lindman, Lance Ippolito, and Nate Tucci — are tracking the 3–5 stocks that actually move the market and sharing their #1 trade setup each day.tc pixel
See More Headlines

GNMSF Stock Analysis - Frequently Asked Questions

Genmab A/S's stock was trading at $207.38 on January 1st, 2025. Since then, GNMSF shares have increased by 54.3% and is now trading at $320.00.

Genmab A/S (OTCMKTS:GNMSF) issued its earnings results on Thursday, August, 7th. The company reported $5.42 earnings per share for the quarter, topping the consensus estimate of $3.99 by $1.43. The business had revenue of $925 million for the quarter, compared to the consensus estimate of $949.06 million. Genmab A/S had a trailing twelve-month return on equity of 21.03% and a net margin of 37.53%.

Shares of GNMSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/07/2025
Today
10/13/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:GNMSF
CIK
1434265
Employees
2,682
Year Founded
1999

Profitability

EPS (Trailing Twelve Months)
$19.92
Trailing P/E Ratio
16.06
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$1.14 billion
Net Margins
37.53%
Pretax Margin
42.63%
Return on Equity
21.03%
Return on Assets
16.98%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.22
Quick Ratio
6.20

Sales & Book Value

Annual Sales
$3.12 billion
Price / Sales
6.77
Cash Flow
$15.43 per share
Price / Cash Flow
20.74
Book Value
$80.53 per share
Price / Book
3.97

Miscellaneous

Outstanding Shares
66,070,000
Free Float
65,057,000
Market Cap
$21.14 billion
Optionable
Not Optionable
Beta
0.95

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (OTCMKTS:GNMSF) was last updated on 10/13/2025 by MarketBeat.com Staff
From Our Partners